Management, Outcomes, and Predictors of Mortality of Cryptococcus Infection in Patients Without HIV: A Multicenter Study in 46 Hospitals in Australia and New Zealand
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciae630 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Julien Coussement und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Cryptococcosis, Antifungal Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Limited data exist regarding outcomes of cryptococcosis in patients without human immunodeficiency virus (HIV), and few studies have compared outcomes of Cryptococcus gattii versus Cryptococcus neoformans infection.
Methods
We conducted a retrospective study in 46 Australian and New Zealand hospitals to determine the outcomes of cryptococcosis in patients without HIV diagnosed between 2015 and 2019 and compared outcomes of C. gattii versus C. neoformans infections. Multivariable analysis identified predictors of mortality within 1 year.
Results
Of 426 patients, 1-year all-cause mortality was 21%. Cryptococcus gattii infection was associated with lower mortality than C. neoformans (adjusted odds ratio [OR], 0.47; 95% confidence interval [CI], .23–.95), while severe neurological symptoms at presentation were the strongest predictor of death (adjusted OR, 8.46; 95% CI, 2.99–23.98). Almost all (99.5%) patients with central nervous system (CNS) infection received induction antifungal therapy versus 27.7% with isolated pulmonary cryptococcosis. The most common regimen in CNS disease was liposomal amphotericin B with flucytosine (93.8%; mean duration, 31 ± 13 days). Among patients with CNS cryptococcosis, C. gattii infection was associated with higher risk of immune reconstitution inflammatory response (C-IRIS) than C. neoformans (21% versus 3%, P < .001). Nineteen patients received amphotericin B-based re-induction therapy for suspected relapse, but none had microbiological relapse. Serum cryptococcal antigen positivity and lung imaging abnormalities resolved slowly (resolution at 1 year in 25% and 34% of patients, respectively).
Conclusions
Compared with C. neoformans, C. gattii infection demonstrated lower mortality but higher C-IRIS risk in CNS infection. Severe neurological symptoms were the strongest predictor of mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Infectious Diseases, Guadeloupe University Hospital, Pointe-a-Pitre, Guadeloupe.
- Department of Microbiology, PathWest Laboratory Medicine, and Department of Infectious Diseases, Fiona Stanley Hospital, Murdoch, Washington, Australia.
- Department of Infectious Diseases, Royal Perth Hospital, Perth, Washington, Australia.
- Royal Adelaide Hospital, Adelaide, South Australia, Australia.
- Flinders Medical Centre, Bedford Park, South Australia, Australia.
ORCID-Profile: Julien Coussement, Christopher H Heath, Rebekah J Lane, Anthony Longhitano, Blake Nield, Sarah A Lynar, Simeon J Crawford, Benjamin J Smith, Andrew P Gador-Whyte, Andrew A Mahony, Julia C Howard, Caitlin L Keighley, Louise Cooley, Jennifer A O'Hern, Caroline Bartolo, Victor Au Yeung, Benjamin W Teh
Zitieren
APA
Coussement, J., Heath, C. H., Roberts, M. B., Lane, R. J., Spelman, T., Smibert, O. C., Longhitano, A., Morrissey, C. O., Nield, B., Tripathy, M., Davis, J. S., Kennedy, K. J., Lynar, S. A., Crawford, L. C., Crawford, S. J., Smith, B. J., Gador-Whyte, A. P., Haywood, R., Mahony, A. A., …, & Australian and New Zealand Study Group for Cryptococcosis in Patients Without HIV Infection (2025). Management, Outcomes, and Predictors of Mortality of Cryptococcus Infection in Patients Without HIV: A Multicenter Study in 46 Hospitals in Australia and New Zealand. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae630
Vancouver
Coussement J, Heath CH, Roberts MB, Lane RJ, Spelman T, Smibert OC, et al. Management, Outcomes, and Predictors of Mortality of Cryptococcus Infection in Patients Without HIV: A Multicenter Study in 46 Hospitals in Australia and New Zealand. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciae630
BibTeX
@article{Coussement2025,
author = {Coussement, Julien and Heath, Christopher H and Roberts, Matthew B and Lane, Rebekah J and Spelman, Tim and Smibert, Olivia C and Longhitano, Anthony and Morrissey, C Orla and Nield, Blake and Tripathy, Monica and Davis, Joshua S and Kennedy, Karina J and Lynar, Sarah A and Crawford, Lucy C and Crawford, Simeon J and Smith, Benjamin J and Gador-Whyte, Andrew P and Haywood, Rose and Mahony, Andrew A and Howard, Julia C and Walls, Genevieve B and O'Kane, Gabrielle M and Broom, Matthew T and Keighley, Caitlin L and Bupha-Intr, Olivia and Cooley, Louise and O'Hern, Jennifer A and Jackson, Justin D and Morris, Arthur J and Bartolo, Caroline and Tramontana, Adrian R and Grimwade, Katherine C and Au Yeung, Victor and Chean, Roy and Woolnough, Emily and Teh, Benjamin W and Slavin, Monica A and Chen, Sharon C A and Australian and New Zealand Study Group for Cryptococcosis in Patients Without HIV Infection, Australian and New Zealand Study Group for Cryptococcosis in Patients Without HIV Infection},
title = {Management, Outcomes, and Predictors of Mortality of Cryptococcus Infection in Patients Without HIV: A Multicenter Study in 46 Hospitals in Australia and New Zealand},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciae630}
}
EUVIMED